Navigation Links
Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
Date:12/23/2009

s with the blurring of central vision or acute vision loss. The severity of this blurring may range from mild to profound loss of vision. The Wisconsin Epidemiologic Study of Diabetic Retinopathy found that over a 10-year period approximately 19% of diabetics studied were diagnosed with DME. Based on this study and the current U.S. diabetic population, Alimera estimates that there will be an incidence of approximately 340,000 cases of DME annually in the United States. As the population of people with diabetes increases, Alimera expects the annual incidence of diagnosed DME to increase as well.

About Iluvien®

Iluvien is an investigative, extended release intravitreal insert that Alimera is developing for the treatment of DME. Each Iluvien insert is designed to provide a therapeutic effect of up to 36 months by delivering sustained sub-microgram levels of fluocinolone acetonide (FA). Iluvien is inserted in the back of the patient's eye to a position that takes advantage of the eye's natural fluid dynamics. Iluvien is inserted with a device that employs a 25-gauge needle, which allows for a self-sealing wound.

About Alimera Sciences, Inc.

Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently the company is focused on diseases affecting the back of the eye, or retina. Its most advanced product candidate is Iluvien®, which is being developed for the treatment of diabetic macular edema, or DME.

Alimera is also pursuing the development, license and acquisition of rights to compounds and technologies with the potential to treat diseases of the eye that Alimera believes are not well treated by current therapies. Alimera has entered into agreements with Emory University, where by it acquired exclusive, worldwide rights under patent applications covering two classes of nicotin
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting
2. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
3. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
4. Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
5. DSMB Again Supports Continuation of Alimera Sciences Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
6. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
7. China Medicine Announces Changes to Management Team
8. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
9. Jennerex Announces Presentations at Upcoming Conferences
10. Macomb County Announces Final 2009 H1N1 Clinic
11. Access MediQuip Announces Release of Partners in Focus Provider Portal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... NEW YORK , July 29, 2014 /PRNewswire/ ... team of Caremark Rx, Drew Crawford today ... PBM365 is the leading independent media source dedicated to ... and opinion on the pharmacy benefit management (PBM) industry ... timely coverage of, and context behind, industry news.   The ...
(Date:7/29/2014)... July 29, 2014  Roche (SIX: RO, ROG; OTCQX: ... Clinical Chemistry (AACC) 2014 Clinical Lab Expo today by ... unique ways Roche is partnering with customers to redefine ... tell us every day that they,re looking for a ... in their labs and offices," said Jack Phillips ...
(Date:7/29/2014)... Laboratory (IL) today announced the launch of its new corporate ... of a comprehensive rebranding effort by Werfen, the parent company ... , in 1959, IL has been part of the ... the group include Inova Diagnostics ( San Diego, CA ... ).  Like IL, these three companies are focused on ...
Breaking Medicine Technology:Drew Crawford Announces Launch of PBM365 Media 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3
... 2007 -,Icagen, Inc. (NASDAQ: ICGN) today announced that ... at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference ... 2:00 p.m. ET., There will be a live ... will be accessible through a link posted on,the ...
... --,SuperGen, Inc. today announced that Dr. Gregory Berk, ... Towbin Emerging Growth,Opportunities Conference on Thursday, July 12, ... City. , SuperGen's presentation at the C.E. Unterberg, ... at 3:30 p.m.,EDT. A live webcast of the ...
Cached Medicine Technology:Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2
(Date:7/29/2014)... The Latin American poultry feed and feed ... and forecast of revenue. The poultry feed and feed additive ... million and $647.2 million in 2013 to $34,024.0 million and ... 2013 to 2018, respectively. , To get an idea of ... of the Latin American poultry feed and feed additive market ...
(Date:7/29/2014)... UT (PRWEB) July 29, 2014 Frank ... produce powders can help parents add nutrition to their ... “Little Bites – Key market drivers in kids’ foods ... Nutrition, is pleased to announce the interview Frank Davis ... adding the Activz organic vegetable and fruit produce powders ...
(Date:7/29/2014)... News) -- Decorative contact lenses may seem like a ... cause serious eye damage. Decorative contacts should be ... the U.S. Food and Drug Administration (FDA). It,s important ... for these lenses and buy them from a trustworthy ... about the potential health risks associated with decorative contact ...
(Date:7/29/2014)... State College of Medicine, have jointly received nearly ... data research network., The Patient-Centered Outcomes Research Institute ... and Affordable Care Act, awarded the funds to ... Johns Hopkins University -- and each of their ... together to create a Clinical Data Research Network, ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 July 29, 2014 ... home care, is proud to announce that it is a ... inspiring online video segments; Silverado Through a Child's Eye ... , In Silverado Through a Child's Eye , ... her mom at Silverado Beverly Place, a memory care community ...
Breaking Medicine News(10 mins):Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:It's 'Buyer Beware' for Decorative Contact Lenses, FDA Says 2Health News:New network unites university health care research 2Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2
... a tree affords complete protection from the sun, say researchers ... to sit under a tree and assume that the foliage ... the shade for granted, say researchers at Purdue University in ... reveals just how much protecting from harmful ultraviolet B light ...
... a hormone called Leptin, produced by fat cells, could ... at the University of Hopkins said obese people have ... relationship between obesity and clotting risk is not well ... Dr. Daniel T. Eitzman, a cardiologist and assistant professor ...
... Lyme disease linger despite antibiotic treatment.,Lyme disease, caused by ... very long-lasting fatigue and cognitive problems. Even though antibiotic ... treatment would not be enough to clear up the ... of whom were assigned to the antibiotic ceftriaxone while ...
... should not assume sneezing and watery eyes are always due ... months, you may well assume it's a pollen allergy starting ... or diagnosis might be pollen allergy.// ,Doctors at the ... rhinitis. Here the inner lining of the nose is just ...
... the risk of heart disease. Researchers found that women over ... risk of dying from heart disease. Low levels of certain ... of heart attacks.// ,But the positive impact of taking ... and calcium are part of the standard therapy for the ...
... program can accurately diagnose a heart attack even when some ... of more than 1,000 adults who went to the emergency ... 80% of people who were having a heart attack.// ... to rely on the computer program to diagnose patients with ...
Cached Medicine News:Health News:Computer Program can assist to detect Heart Attack 2
For primary and revision cases...
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Performa cemented stem....
Medicine Products: